The Patent Finder

Tesorx Pharma, LLC

Also on record
Records under this name other than the patents Tesorx Pharma, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to Tesorx Pharma, LLC

PatentTitleStatus Expires Confidence
US 11,229,602Formulations for treating bladder cancer
Lapsed on the fee record
Ended Jan 25, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 25, 2026From the USPTO record
US 9,445,995Proliposomal testosterone formulations
Lapsed on the fee record
Ended Sep 20, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 20, 2024From the USPTO record
US 8,957,053Proliposomal testosterone formulations
Formerly held
Lapsed on the fee record
Ended Feb 17, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 17, 2023From the USPTO record
US 9,844,557Proliposomal testosterone formulations
Lapsed on the fee record
Ended Dec 19, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 19, 2021From the USPTO record
US 9,623,033Proliposomal testosterone formulations
Lapsed on the fee record
Ended Apr 18, 2021 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited